# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-020083
Filing Date
2025-10-29
Accepted
2025-10-29 16:30:38
Documents
20
Period of Report
2025-10-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 1062263
2 | GRAPHIC | formdef14a_001.jpg | GRAPHIC | 7719
3 | GRAPHIC | formdef14a_002.jpg | GRAPHIC | 10417
4 | GRAPHIC | proxycard_001.jpg | GRAPHIC | 814659
5 | GRAPHIC | proxycard_002.jpg | GRAPHIC | 1098765
| Complete submission text file | 0001493152-25-020083.txt |  | 6885430

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | aimi-20241231.xsd | EX-101.SCH | 8559
7 | XBRL DEFINITION FILE | aimi-20241231_def.xml | EX-101.DEF | 12223
8 | XBRL LABEL FILE | aimi-20241231_lab.xml | EX-101.LAB | 76183
9 | XBRL PRESENTATION FILE | aimi-20241231_pre.xml | EX-101.PRE | 46162
23 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 194380

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-27072 | Film No.: 251430441
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)